AI assistant
Sending…
Glenmark Pharmaceuticals ltd — Remuneration Information 2019
Nov 14, 2019
62608_rns_2019-11-14_872ed527-b905-4c6e-8380-536814b07a98.pdf
Remuneration Information
Open in viewerOpens in your device viewer
==> picture [131 x 63] intentionally omitted <==
==> picture [7 x 35] intentionally omitted <==
| pursuanttoEmployee Stock Options | Scheme, 2016: |
|---|---|
| NumberofOptions Granted | 20,000 OptionsEachOption represents 1 EquitysharesofRe.1 each |
| NumberofOrdinarysharescovered under the Optionsgranted | 20,000 equity sharesofRe.1 each |
| Vesting period | Tocommence after a periodofone year from thedateofthe grant and extend upto a maximum periodofsixyearsfromthe dateofthegrant |
| Exercise Period | Tocommence from the dateofvestingofstockoptions and mayextend till the expiry ofthe scheme |
| Exercise Price | Rs.600per Option |
More from Glenmark Pharmaceuticals ltd
Investor Presentation
2026
May 29
Investor Presentation
2026
May 29
Earnings Release
2026
May 29
Earnings Release
2026
May 29
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Board/Management Information
2026
May 29
Board/Management Information
2026
May 29
Interim / Quarterly Report
2026
May 29